Intravenous haloperidol for tranquilization in critical care patients: a review and critique
| Autor: | Scott R. Ziehm |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Drug
Male medicine.medical_specialty media_common.quotation_subject Critical Illness Critical Care Nursing behavioral disciplines and activities Food and drug administration Intravenous use Death Sudden Basal Ganglia Diseases Critical care nursing Haloperidol medicine Humans Neuroleptic Malignant Syndrome Intensive care medicine Adverse effect Infusions Intravenous Psychomotor Agitation media_common Aged Critically ill business.industry General Medicine Middle Aged Emergency Medicine Female business medicine.drug |
| Zdroj: | AACN clinical issues in critical care nursing. 2(4) |
| ISSN: | 1046-7467 |
| Popis: | The management of agitated, combative, fearful critically ill patients is a significant challenge for critical care nurses. Intravenously administered haloperidol can be effective in treating these patients. Because the U.S. Food and Drug Administration has not approved the use of haloperidol intravenously, there are no widely accepted guidelines for intravenous use of this drug. This chapter reviews the literature and provides information to critical care nurses in the use of intravenous haloperidol. Haloperidol’s pharmacologic properties are described; several published case studies are reviewed; and potential adverse effects associated with haloperidol’s use are presented |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|